The Republicans have had quite a bit of an uphill struggle to get their tax reform plan approved; the main issue has been that even many of their own party members have remained skeptical about the reforms proposals. President Trump has, in fact, be..

Novartis AG (NYSE: NVS) announced Wednesday that the US Food and Drug Administration (FDA) has approved Kymriah (TM)(tisagenlecleucel) suspension for intravenous infusion, the first chimeric antigen receptor T cell (CAR-T) therapy, for the treatment..